FindTrial
Sign In

Early Recurrence of New ischemic Lesions in Extracranial/intracranial artery STenosis : Importance of Residual Platelet Reactivity (ERNEST trial)

Early Recurrence of New ischemic Lesions in Extracranial/intracranial artery STenosis : Importance of Residual Platelet Reactivity (ERNEST trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001492
Enrollment
60
Registered
2015-05-19
Start date
2011-08-08
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University Ansan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.patients aged from 20 to 85 years old 2.acute ischemic patients admitted within symptom onset < 48 hour 3.acute stroke attributed to large artery atherosclerosis 4.clopidogrel naïve patients 5.patients with Informed consent

Exclusion criteria

Exclusion criteria: 1.patients treated with IV Thrombolytics 2.pateents with stroke attributed to non-atherosclerotic arteriopathy such as Moyamoya disease, cervical dissection and fibromuscular dysplasia

Design outcomes

Primary

MeasureTime frame
Presence of new ischemic lesions in follow-up diffusion-weighted image—

Secondary

MeasureTime frame
Symptomatic intracranial hemorrhage (ICH) in follow-up gradient echo MR image and major hemorrhage(any symptomatic ICH or systemic hemorrhage requiring hospitalization, blood transfusion or surgery—

Countries

Korea, Republic of

Contacts

Public ContactJin-Man Jung

Korea University Ansan Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026